In this study, we present experimental evidence that AKT1E17K is a bona fide oncogene for mammary epithelium, being able to efficiently initiate breast cancer in mice by using a ROSA26-based engineered mouse model for the expression of the oncogenic AKT1(E17K) mutation in the mammary gland. Here, AKT1 is linked to breast cancer.